Delivery Order SPE2DX22D0010-SPE2D826FBS23
Award Date 12/11/25
Potential Completion Date 12/12/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Concerta ER Tabs 27mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $8,217.60 with an ultimate completion date of August 12, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a $5,190.36 delivery order to AmerisourceBergen Drug Corp for Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, issued on October 29, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by October 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a $21,395.38 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This award was competitively awarded...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Concerta ER Tabs 27mg, a medication used to treat attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $34,825.79, represents a non-set-aside competitive award and is scheduled for completion by July 31, 2025. The contract will be fulfilled from AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,443.00 to AmerisourceBergen Drug Corp for the supply of Concerta ER tablets 18mg, a prescription medication commonly used to treat attention-deficit/hyperactivity disorder. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Concerta ER tablets 54mg, with a ceiling value of $2,156.95. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to conclude on December 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $67,832.46, represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency's Medical Supply Chain awarded a $26,125.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Concerta ER Tablets 27mg, with an ultimate completion date of August 11, 2025. This non-set-aside competitive award was issued on August 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs, specifically...
- The Defense Logistics Agency awarded a delivery order valued at $1,196.31 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 18 mg, a prescription medication used to treat attention deficit hyperactivity disorder. This firm fixed price, non-set-aside contract was awarded on December 1, 2025, with completion scheduled for December 2, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,591.14 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Concerta ER Tablets 36mg. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...